[ad_1]
Following is a summary of current health news
Bill Gates backs $ 30 million push for early Alzheimer's diagnoses
Billionaire Bill Gates and Estee Lauder Cos chairman emeritus Leonard Lauder on Tuesday said they will be awarded $ 30 million over three years to encourage the development of new tests for early detection of Alzheimer's disease. For Microsoft co-founder Gates, launch of the Diagnostics Accelerator program follows a $ 50 million personal investment announcement in the Dementia Discovery Fund, a venture capital fund aimed at bringing together industry and government to seek treatments for brain-wasting
Judge rules for trump administration
A federal judge ruled on Monday against birth control organizations that sought trump administration from shifting to a federal family-planning grant program toward priorityizing groups that are faith-based and counsel abstinence. Three planned family organizations along with the National Family Planning & Reproductive Health Association, which were later combined, in May challenging guidelines the Department of Health and Human Services (HHS) issued in February.
surge, shares jump
Johnson & Johnson on Tuesday reported better than expected sales of pharmaceuticals surged 20 percent despite a sharp decline in blockbuster arthritis drug Remicade, and its actions rose more than 4 percent. The healthcare conglomerate also expressed confidence that the last week's finding of a Missouri Jury that J & J's Talc-based cancer products, and an order to pay a record $ 4.69 billion to defendants, would not stand.
China heart drug sold globally may have had impurity since 2012
A common blood pressure and heart disease manufactured in bulk by a Chinese company and sold worldwide may have contained an impurity linked to cancer since 2012, European regulators said on Tuesday. Zhejiang Huahai Pharmaceutical six years ago
Wide variation in follow-up care for women with low-risk bad cancer
The kind of imaging US women receive after treatment for non-metastatic bad cancer can vary widely, a new study finds. While some women do not get the recommended annual mammograms, others with similar low-risk cancers are receiving expensive PET and full body scans, which exposes patients to higher levels of radiation, the researchers reported in the Journal of the National Comprehensive Cancer Network.
Teens who spend time surfing the web, playing games and chatting with friends on the Internet US study suggests. Researchers followed more than 2,500 Los Angeles high school students over two years, asking for symptoms of attention deficit hyperactivity disorder (ADHD) and their digital media habits
Roche touts new flu as Tamiflu suffers generics hit
Swiss drugmaker Roche's hope of recapturing lost ground in the generics-flooded influenza market has a boost after a late-stage study of its new medications at high risk of complications. Some badysts, however, have only met expectations for the drug, baloxavir marboxil, since previously published results have been shown to be less effective than in the past.
Mylan signs US license deal on Humira with AbbVie
AbbVie Inc said on Tuesday it signed a US licensing deal with Mylan NV for its proposed biosimilar to AbbVie 's blockbuster drug Humira, in a move that will give you more control over the competition. The deal is in line with AbbVie's strategy to defend rivals of the world's best-selling drug prescription until 2023, giving the company more time to bolster its pipeline with new cash
Evidence to support ' breakthrough 'drugs often very limited: study
The 46 drugs given approval through 2017 as part of the US Food and Drug Administration's Breakthrough Therapy program has often been sent to patients without a double-blind study, direct measurement of benefit, or Yale University and the Yale School of Medicine. "Our research suggests that FDA approval of these breakthrough therapies is based on shorter and shorter clinical trials than FDA approval of non-breakthrough therapy drugs," Dr. Joseph Ross coauthor told Reuters Health in an email.
UnitedHealth second quarter medical costs miss estimates, shares slide
UnitedHealth Group Inc, the largest US health insurer, on Tuesday reported second-quarter sector. United Kingdom is the first health insurer to report earnings, and Wall Street investors took their toll in the shares of Anthem Inc., Cigna Corp. and Humana Inc.
(Devdiscourse staff and is auto-generated from a syndicated feed.)
[ad_2]
Source link
